How to manage the non-ocular complications from hyaluronic acid? Proposal for a therapeutic algorithm
DOI:
https://doi.org/10.29176/2590843X.2061Keywords:
Follow-up, Guidelines, Hyaluronic acid, Treatment, Vascular occlusion, VascularAbstract
Background: In the last years, there has been a documented increase in the frequency of injectable aesthetic procedures, consequently leading to a rise in complication rates.
Among these, vascular occlusion is the most feared due to its high morbidity for the patient and the stress-induced confusion it may cause in the injecting doctor. Due to this, it is imperative to establish a clear and simple step-by-step approach that injecting physicians can quickly access. This would serve as a tool to calm and guide them in the therapeutic approach swiftly, effectively, and efficiently.
Methods: A literature search was conducted, based on this review and the experience of the injectors, objectives were determined to optimize the patient's attention experiencing vascular events due to hyaluronic acid. An algorithm was developed to incorporate the most validated appropriate clinical practices in the real-life setting.
Results: Based on injectors recommendation with over ten years of experience and on literature reviews and evidence, a simple and clear therapeutic algorithm was created. It clarifies a practical step-by-step approach to be followed in the case of a vascular adverse event due to hyaluronic acid.
Conclusion: Although there are related algorithms reported previously, we offer a guided step by step, from the moment of the patient’s initial assessment to the final follow-up when it is decided to discharge the patient. With information that can be forgotten due to stress produced by the adverse event, reminders and basic information such as what the emergency kit should have.
Author Biographies
Laura Margarita Arango Bedoya, Universidad Pontificia Bolivariana, Medellín, Colombia
Dermatología Estética, Universidad Pontificia Bolivariana, Medellín, Colombia.
Jaime Rengifo-Palacios, Universidad Pontificia Bolivariana, Medellín, Colombia
Dermatología Estética, Universidad Pontificia Bolivariana, Medellín, Colombia.
Maria Paulina Uribe-Posada, Universidad Pontificia Bolivariana, Medellín, Colombia
Dermatología Estética, Universidad Pontificia Bolivariana, Medellín, Colombia.
References
Arango-Bedoya LM, Rengifo-Palacios J, Uribe-Posada MP. Oclusión vascular por ácido hialurónico de hidratación: una complicación inusual pero posible. Piel (Barc). 2024
FDA Executive summary general issues panel meeting on dermal fillers. [consultado 1 de Mar 2024]. Disponible en: https://www.fda.gov/media/146870/download; 2023
Heydenrych I, De Boulle K, Kapoor KM, Bertossi D. The 10-Point Plan 2021: Updated Concepts for Improved Procedural Safety During Facial Filler Treatments. Clin Cosmet Investig Dermatol. 2021 Jul 6;14:779-814
Murray G, Convery C, Walker L, Davies E. Guideline for the Management of Hyaluronic Acid Filler-induced Vascular Occlusion. J Clin Aesthet Dermatol. 2021 May;14(5):E61-E69. Epub 2021 May 1.
Soares DJ MD. Bridging a Century-Old Problem: The Pathophysiology and Molecular Mechanisms of HA Filler-Induced Vascular Occlusion (FIVO)-Implications for Therapeutic Interventions. Molecules. 2022;27(17):5398. Published 2022 Aug 24.
Murray G, Convery C, Walker L, Davies E. Guideline for the Safe Use of Hyaluronidase in Aesthetic Medicine, Including Modified High-dose Protocol. J Clin Aesthet Dermatol. 2021 Aug;14(8):E69-E75. Epub 2021 Aug 1. PMID: 34840662; PMCID: PMC8570661.
Delorenzi C. New High Dose Pulsed Hyaluronidase Protocol for Hyaluronic acid filler vascular events. Aesthet Surg J. 2017;37(7):814–825
Schelke LW, Velthuis P, Kadouch J, Swift A. Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillers. J Am Acad Dermatol. 2019. S0190–9622(19)32392–8.
Choi SY, Shin SH, Seok J, Yoo KH, Kim BJ. Management strategies for vascular complications in hyaluronic acid filler injections: A case series analysis. J Cosmet Dermatol. 2023 Dec;22(12):3261-3267.
The Duration of Hyaluronidase and Optimal Timing of Hyaluronic Acid (HA) filler Reinjection after Hyaluronidase Injection. J Cosmet Laser Ther. 2017;20(1)
Darling MD, Peterson JD, Fabi SG. Impending necrosis after injection of hyaluronic acid and calcium hydroxylapatite fillers: report of 2 cases treated with hyperbaric oxygen therapy. Dermatol Surg. 2014;40:1049–1052.
Worley N, Lupo M, Holcomb K et al. Hyperbaric oxygen treatment of keratitis following Facial hyaluronic acid injection. Ochsner J. 2020;20(2):193–196
Kroumpouzos G, Treacy P. Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations. JMIR Dermatol. 2024;7:e50403. Published 2024 Jan 17.
Borzabadi-Farahani A, Mosahebi A, Zargaran D. A Scoping Review of Hyaluronidase Use in Managing the Complications of Aesthetic Interventions. Aesthetic Plast Surg. 2024;48(6):1193-1209.
Fakih-Gomez N, Porcar Plana CA, Verano-Garcia A, Muñoz-Gonzalez C, Kadouch J. Updated Filler Emergency Kit: Next-Generation Emergency Solution. Aesthetic Plast Surg. 2024 Mar;48(6):1174-1180. doi: https://doi.org/10.1007/s00266-023-03722-3.
Sito G, Manzoni V, Sommariva R (2019) Vascular complications after facial filler injection. J Clin Aesthet Dermatol 12(6):E65–E72. https://doi.org/10.1111/ijcp.14675
Schelke L, Decates T, Kadouch J, Velthuis P (2020) Incidence of vascular obstruction after filler injections. Aesthet Surg J 40(8):NP457–NP460. https://doi.org/10.1093/asj/sjaa086
Lemperle G, Rullan PP, Gauthier-Hazan N (2006) Avoiding and treating dermal filler complications. Plast Reconstr Surg 118(3 SUPPL.):92–107. https://doi.org/10.1097/01.prs.0000234672.69287.77
Fakih-Gomez N, Orte-Aldea MC, Poonja K, Khanna D (2019). Hyaluronic acid filler emergency kit. Am J Cosmet Surg 36(4):183–190. https://doi.org/10.1177/0748806818825214
Rzany B, DeLorenzi C (2015) Understanding, avoiding, and managing severe filler complications. Plast Reconstr Surg 136(5):196S-203S. https://doi.org/10.1097/PRS.0000000000001760
Cavallini M, Gazzola R, Metalla M, Vaienti L (2013) The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers. Aesthet Surg J 33(8):1167–1174. https://doi.org/10.1177/1090820X13511970
Schelke LW, Velthuis PJ, Decates T et al (2023) Ultrasoundguided targeted vs regional flooding: a comparative study for improving the clinical outcome in soft tissue filler vascular adverse event management. Aesthet Surg J 43(1):86–96
Saint-Cyr M, Wong C, Schaverien M, Mojallal A, Rohrich RJ (2009). The perforasome theory: vascular anatomy and clinical implications. Plast Reconstr Surg 124(5):1529–1544. https://doi.org/10.1097/PRS.0b013e3181b98a6c
Taylor GI, Corlett RJ, Ashton MW (2017) The functional angiosome: clinical implications of the anatomical concept. Plast Reconstr Surg 140(4):721–733. https://doi.org/10.1097/PRS.0000000000003694
Ramamoorthy S, Cidlowski JA (2016) Corticosteroids: mechanisms of action in health and disease. Rheum Dis Clin North Am 42(1):15–31. https://doi.org/10.1016/j.rdc.2015.08.002
Galie` N (2009) Phosphodiesterase type 5 inhibitors. Pulm Hypertens 5(August):350–354. https://doi.org/10.2165/00063030-200013020-00002
Alam M, Dover JS (2007) Management of complications and sequelae with temporary injectable fillers. Plast Reconstr Surg 120(6S):98–105. https://doi.org/10.1097/01.prs.0000248859.14788.60
Wyns H, Meyer E, Watteyn A et al (2013) Pharmacokinetics of dexamethasone after intravenous and intramuscular administration in pigs. Vet J 198(1):286–288. https://doi.org/10.1016/j.tvjl.2013.06.015
Valderrama-Beltrán S, Cortés J, Caro M, et al. (2019). Clinical Practice Guide for the Diagnosis and Management of Skin and Soft Tissue Infections in Colombia. Infectio, 23(4), 318-346. https://doi.org/10.22354/in.v23i4.805
Jajoria H, Venkataram A, Mysore V (2020) Importance of choke vessels in injectable fillers. J Cutan Aesthet Surg 13(3):185–190
Ashton MW, Taylor GI, Corlett RJ (2018) The role of anastomotic vessels in controlling tissue viability and defining tissue necrosis with special reference to complications following injection of hyaluronic acid fillers. Plast Reconstr Surg 141:818e–830e. https://doi.org/10.1097/PRS.0000000000004287
Sunderkötter C, Becker K. Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment. J Dtsch Dermatol Ges. 2015 Jun;13(6):501-24; quiz 525-6. English, German. doi: https://doi.org/10.1111/ddg.12721. PMID: 26018361.
Snozzi P, van Loghem JAJ. Complication Management following Rejuvenation Procedures with Hyaluronic Acid Fillers-an Algorithm-based Approach. Plast Reconstr Surg Glob Open. 2018 Dec 17;6(12):e2061.
DeLorenzi C. Complications of injectable fillers, part 2: vascular complications. Aesthet Surg J. 2014;34:584.
Kim JH, Ahn DK, Jeong HS, Suh IS. Treatment algorithm of complications after filler injection: based on wound healing process. J Korean Med Sci. 2014 Nov;29 Suppl 3(Suppl 3):S176-82.
How to Cite
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Laura Margarita Arango Bedoya, Jaime Rengifo-Palacios, Maria Paulina Uribe-Posada
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
